Seroprotection against serogroup C meningococcal disease
- 5 June 2008
- Vol. 336 (7659) , 1447-1448
- https://doi.org/10.1136/bmj.39577.487558.be
Abstract
Footnotes Research, doi: 10.1136/bmj.39563.545255.AE Competing interests: PTH has conducted clinical trials on behalf of St George’s, University of London, which were sponsored by vaccine manufacturers, including manufacturers of meningococcal vaccines, and has received funds from vaccine manufacturers to attend scientific meetings. Provenance and peer review: Commissioned; not externally peer reviewed.Keywords
This publication has 11 references indexed in Scilit:
- Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyBMJ, 2008
- Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United KingdomThe Journal of Infectious Diseases, 2006
- Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaPublished by Wiley ,2006
- Population-Based Analysis of Meningococcal Disease Mortality in the United StatesThe Pediatric Infectious Disease Journal, 2006
- Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate VaccinePublished by American Medical Association (AMA) ,2004
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysisBMJ, 2003
- Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccinationThe Lancet, 2002
- Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of ProtectionInfection and Immunity, 2001
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969